| Product Code: ETC7739002 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Genomic Tests Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Genomic Tests Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Genomic Tests Market - Industry Life Cycle |
3.4 Japan Genomic Tests Market - Porter's Five Forces |
3.5 Japan Genomic Tests Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Genomic Tests Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Japan Genomic Tests Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Japan Genomic Tests Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Japan Genomic Tests Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in Japan |
4.2.2 Growing awareness and adoption of personalized medicine in the healthcare sector |
4.2.3 Technological advancements in the field of genomics leading to more accurate and cost-effective tests |
4.3 Market Restraints |
4.3.1 Stringent regulations and compliance requirements for genomic testing in Japan |
4.3.2 High initial investment and infrastructure costs associated with genomic testing facilities |
5 Japan Genomic Tests Market Trends |
6 Japan Genomic Tests Market, By Types |
6.1 Japan Genomic Tests Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Genomic Tests Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Genomic Tests Market Revenues & Volume, By Predictive & Presymptomatic Testing, 2021- 2031F |
6.1.4 Japan Genomic Tests Market Revenues & Volume, By Carrier Testing, 2021- 2031F |
6.1.5 Japan Genomic Tests Market Revenues & Volume, By Prenatal & Newborn Testing, 2021- 2031F |
6.1.6 Japan Genomic Tests Market Revenues & Volume, By Diagnostic TestingPharmacogenomic Testing, 2021- 2031F |
6.1.7 Japan Genomic Tests Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Genomic Tests Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Japan Genomic Tests Market Revenues & Volume, By Cytogenetic Testing, 2021- 2031F |
6.2.3 Japan Genomic Tests Market Revenues & Volume, By Biochemical Testing, 2021- 2031F |
6.2.4 Japan Genomic Tests Market Revenues & Volume, By Molecular Testing, 2021- 2031F |
6.3 Japan Genomic Tests Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Japan Genomic Tests Market Revenues & Volume, By Cancer diagnosis, 2021- 2031F |
6.3.3 Japan Genomic Tests Market Revenues & Volume, By Genetic Disease Diagnosis, 2021- 2031F |
6.3.4 Japan Genomic Tests Market Revenues & Volume, By Cardiovascular Disease Diagnosis, 2021- 2031F |
6.3.5 Japan Genomic Tests Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Genomic Tests Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Japan Genomic Tests Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.4.3 Japan Genomic Tests Market Revenues & Volume, By Research Centers and Academic & Government Institutes, 2021- 2031F |
6.4.4 Japan Genomic Tests Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.5 Japan Genomic Tests Market Revenues & Volume, By Other End Users, 2021- 2031F |
7 Japan Genomic Tests Market Import-Export Trade Statistics |
7.1 Japan Genomic Tests Market Export to Major Countries |
7.2 Japan Genomic Tests Market Imports from Major Countries |
8 Japan Genomic Tests Market Key Performance Indicators |
8.1 Number of research and development collaborations in the genomics sector in Japan |
8.2 Adoption rate of genomic testing by healthcare providers in Japan |
8.3 Percentage increase in the number of genetic testing facilities across different regions in Japan |
9 Japan Genomic Tests Market - Opportunity Assessment |
9.1 Japan Genomic Tests Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Genomic Tests Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Japan Genomic Tests Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Japan Genomic Tests Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Japan Genomic Tests Market - Competitive Landscape |
10.1 Japan Genomic Tests Market Revenue Share, By Companies, 2024 |
10.2 Japan Genomic Tests Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here